Health Care & Life Sciences » Pharmaceuticals | Krebs Biochemicals & Industries Ltd.

Krebs Biochemicals & Industries Ltd. | Balance Sheet

Fiscal year is April-March. All values INR Millions.
2013
2015
2016
2017
2018
Cash & Short Term Investments
3
63
3
1
8
Total Accounts Receivable
46
25
1
16
3
Inventories
334
59
57
56
117
Other Current Assets
1
1
33
59
44
Total Current Assets
384
149
94
132
172
Net Property, Plant & Equipment
506
510
1,032
1,024
1,011
Total Investments and Advances
-
5
-
-
11
Long-Term Note Receivable
272
217
-
-
-
Intangible Assets
71
75
13
36
34
Other Assets
125
116
26
29
30
Total Assets
1,376
1,084
1,164
1,221
1,259
ST Debt & Current Portion LT Debt
356
38
53
48
-
Accounts Payable
197
165
124
110
178
Other Current Liabilities
153
106
119
160
272
Total Current Liabilities
706
310
295
317
450
Long-Term Debt
525
571
253
428
517
Provision for Risks & Charges
20
21
36
28
37
Deferred Taxes
17
13
-
-
-
Other Liabilities
45
-
450
433
433
Total Liabilities
1,297
902
1,034
1,206
1,437
Common Equity (Total)
76
13
126
11
178
Total Shareholders' Equity
76
13
126
11
178
Total Equity
76
13
126
11
178
Liabilities & Shareholders' Equity
1,376
1,084
1,164
1,221
1,259
Non-Equity Reserves
4
196
4
4
-

About Krebs Biochemicals & Industries

View Profile
Address
Plot No.34, 8-2-577/B
Hyderabad TS 500034
India
Employees -
Website http://krebsbiochem.com
Updated 09/14/2018
Krebs Biochemicals & Industries Ltd. engages in the manufacture and selling of pharmaceutical ingredients and intermediates. It provides synthetic products, including lavastatin, simvastatin and ephedrine as well as pseudo ephedrine. The company was founded by Ravindranath Tagore Ravi on December 2, 1991 and is headquartered in Hyderabad, India.